Realtime News
Performance
29.11.2021

EQS-Reg 29.11.21 12:36 EQS-Reg: Travis Perkins
Travis Perkins: Directorate Change
EQS-Reg 29.11.21 12:27 EQS-Reg: Chelverton UK Dividend Trust plc
Chelverton UK Dividend Trust plc: Net Asset Value(s)
EQS-Reg 29.11.21 12:15 EQS-Reg: ITI FUNDS RTS EQUITY UCITS ETF SICAV
ITI FUNDS RTS EQUITY UCITS ETF SICAV: Net Asset Value(s)
EQS-Reg 29.11.21 12:15 EQS-Reg: ITI FUNDS RUSSIA-FOCUSED USD EUROBOND
ITI FUNDS RUSSIA-FOCUSED USD EUROBOND: Net Asset Value(s)
EQS-Reg 29.11.21 12:06 EQS-Reg: Aroundtown SA
Aroundtown SA: Release of a capital market information
EQS-Reg 29.11.21 11:43 EQS-Reg: Amundi Asset Management
Amundi Asset Management: Final terms
EQS-Reg 29.11.21 11:35 EQS-Reg: Amundi Asset Management
Amundi Asset Management: Final Terms
EQS-Reg 29.11.21 11:15 EQS-Reg: AMUNDI INDEX FTSE EPRA NAREIT GLOBA[...]
AMUNDI INDEX FTSE EPRA NAREIT GLOBAL UCITS ETF DR: Net Asset V[...]
EQS-Reg 29.11.21 10:17 EQS-Reg: AMUNDI INDEX MSCI EUROPE UCITS ETF DR
AMUNDI INDEX MSCI EUROPE UCITS ETF DR: Net Asset Value(s)
EQS-Reg 29.11.21 10:17 EQS-Reg: AMUNDI INDEX MSCI NORTH AMERICA UCI[...]
AMUNDI INDEX MSCI NORTH AMERICA UCITS ETF DR: Net Asset Value(s)
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI MSCI EMU ESG LEADERS SELECT [...]
AMUNDI MSCI EMU ESG LEADERS SELECT - UCITS ETF DR - EUR (C): N[...]
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI INDEX MSCI WORLD UCITS ETF DR
AMUNDI INDEX MSCI WORLD UCITS ETF DR: Net Asset Value(s)
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI ETF MSCI JAPAN - B
AMUNDI ETF MSCI JAPAN - B: Net Asset Value(s)
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI INDEX MSCI PACIFIC EX JAPAN [...]
AMUNDI INDEX MSCI PACIFIC EX JAPAN SRI - UCITS ETF DR - USD (C[...]
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI ETF JAPAN TOPIX UCITS ETF - JPY
AMUNDI ETF JAPAN TOPIX UCITS ETF - JPY: Net Asset Value(s)
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI ETF NASDAQ-100 - B
AMUNDI ETF NASDAQ-100 - B: Net Asset Value(s)
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI ETF JPX-NIKKEI 400 UCITS - B
AMUNDI ETF JPX-NIKKEI 400 UCITS - B: Net Asset Value(s)
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI ETF RUSSELL 2000 UCITS - B
AMUNDI ETF RUSSELL 2000 UCITS - B: Net Asset Value(s)
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI ETF FTSE EPRA EUROPE REAL ES[...]
AMUNDI ETF FTSE EPRA EUROPE REAL ESTATE UCITS ETF: Net Asset V[...]
EQS-Reg 29.11.21 10:16 EQS-Reg: AMUNDI INDEX MSCI EUROPE - UCITS ET[...]
AMUNDI INDEX MSCI EUROPE - UCITS ETF DR (D): Net Asset Value(s)

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

MS Industrie AG

Original-Research: MS Industrie AG (von Montega AG): Kaufen

29. November 2021